unknown
Stage
2018
Founded
1
Investors
About
Interius BioTherapeutics is a clinical-stage biotechnology company that develops targeted, programmable lentiviral vectors (LENTIVECTOR platform) to deliver genetic medicines in vivo. Its platform is being applied to enable off-the-shelf genetic therapies, including approaches to simplify CAR T–style treatments for cancer and autoimmune diseases.
Explore Interius BioTherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.